$278.25-5.66% · 3M
Moving avg
1W-1.50%
1M-6.57%
3M-2.46%
6M-4.53%
YTD-0.31%
1Y-4.17%
3Y-4.00%
5Y+31.93%
52-week range
$239.5151% of range$315.47
Company health
Value6/6
Growth5/6
Profitability3/6
Health2/6
Dividend5/6
Bull vs bear
Strengths
- Reasonably valued at 12.2x earnings
- Analysts see 23% upside to a $342 target
- Analyst consensus is "Buy"
- High return on equity (1516%)
- Revenue compounding 21% a year
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$73.52B
Enterprise value
$100.46B
P/E ratio (TTM)
12.21x
P/S ratio (TTM)
0.28x
EV/EBITDA
8.23x
Per share & returns
EPS (TTM)
$23.95
Dividend yield
2.12%
Beta (1Y)
0.30
30-day change
-6.57%
Trading
Volume (24h)
203.79K
Previous close
$277.41
Shares outstanding
264.24M
About Cigna Corporation
Sector
Healthcare
Industry
Medical - Healthcare Plans
Exchange
NYSE
Symbol
CI
Cigna Corporation is a large-cap healthcare company in the Medical - Healthcare Plans industry. Its shares are listed on NYSE (United States) and trade under the ticker CI.
Frequently asked questions
What is Cigna Corporation's market cap?
Cigna Corporation (CI) has a market capitalization of $73.52B.
What is Cigna Corporation's P/E ratio?
Cigna Corporation trades at a price-to-earnings (P/E) ratio of 12.21.
What exchange does CI trade on?
CI trades on NYSE.
Appears in
Eli Lilly and CompanyLLY
$1,220.02-0.02%
$1.15T cap
Johnson & JohnsonJNJ
$261.21+0.13%
$629.49B cap
AbbVie Inc.ABBV
$250.31+0.62%
$442.25B cap
UnitedHealth Group IncorporatedUNH
$403.33-0.56%
$366.28B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.58+1.25%
$332.39B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap